Akebia Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filings
70
Total reported value, excl. options
$30.9 M
Manager Report Date Value ($000) Shares Option Type